✦ LIBER ✦

160 Antitumor therapy with VEGF receptor tyrosine kinase inhibitor ZD6474 in a mouse model of intestinal cancer

✍ Scribed by R.A. Goodlad; A. Ryan; J. Watson; S.R. Wedge; I.T. Pyrah; N. Mandir; R.W. Wilkinson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anticancer effects of ZD6474, a VEGF rec

✍ Fumiko Taguchi; Yasuhiro Koh; Fumiaki Koizumi; Tomohide Tamura; Nagahiro Saijo; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 917 KB

P-359 Results from a phase I study of th

✍ Wheeler, Catherine; Minami, Hironobu; Ebi, Hiromichi; Tahara, Makoto; Sasaki, Ya 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Effects of ZD6474, an orally active inhi

✍ S. Holden; S. Eckhardt; R. Basser; D. Rischin; H. Hurwitz; R. DeBoer; M. Rosenth 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Activity of ZD6474, a vascular endotheli

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 275 KB

165 AZD2171, a potent VEGF receptor tyro

✍ S. Wedge; J. Kendrew; P.J. Valentine; S.R. Brave; S. Barnett; J.M. Jurgensmeier; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A Multicenter Phase II Trial of ZD6474,

✍ Dickler, M.N. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB